Novartis: all 3,900 studies
Page 22 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent LineCompletedNCT05734053
- The Belgian REAL (BE.REAL) RegistryActive, not recruitingNCT05726838
- Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of MelanomaCompletedNCT05714371
- A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South KoreaActive, not recruitingNCT05703516
- Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in FranceActive, not recruitingNCT05697146
- Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence StudyCompletedNCT05677542
- 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-upActive, not recruitingNCT05677451Phase 3
- Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With CapmatinibCompletedNCT05675683
- Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 SkippingCompletedNCT05670730Phase 1/2
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPCCompletedNCT05670106Phase 2
- Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal VasculopathyCompletedNCT05666804Phase 3
- An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the BrainCompletedNCT05666687Phase 1
- A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate CancerActive, not recruitingNCT05658003Phase 2
- Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionCompletedNCT05657158
- Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT05653349Phase 3
- A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsActive, not recruitingNCT05653219Phase 3
- Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque PsoriasisCompletedNCT05650060
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive, not recruitingNCT05648968Phase 3
- Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)Active, not recruitingNCT05639114Phase 3
- Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life SettingActive, not recruitingNCT05633771
- The 'Wearing Off' Effect of DMTCompletedNCT05627271
- Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05626257
- Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)Active, not recruitingNCT05624749Phase 3
- A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved RemissionActive, not recruitingNCT05622708Phase 4
- A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in KoreaCompletedNCT05621733
- French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML PatientsCompletedNCT05619978
- Sacubitril/Valsartan Treated Adult Patients With Chronic Heart FailureCompletedNCT05613140
- Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor BurdenCompletedNCT05611229
- Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I MutationCompletedNCT05611216
- Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic ImpairmentCompletedNCT05599932Phase 1
- A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles TendinopathyCompletedNCT05592990Phase 2
- Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.CompletedNCT05590598Phase 3
- Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract InfectionsCompletedNCT05588804Phase 3
- A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in ChinaCompletedNCT05576792
- Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.CompletedNCT05576779
- Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast CancerCompletedNCT05569187
- Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other TherapiesCompletedNCT05566756
- Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid DiseasesActive, not recruitingNCT05552469Phase 1
- Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia VeraActive, not recruitingNCT05548062
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Comparison of Clinical Outcomes Among Patients Treated With TisagenlecleucelCompletedNCT05541328
- Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy ParticipantsWithdrawnNCT05541159Phase 1
- Risk Perception in Multiple SclerosisCompletedNCT05528666
- Special Drug Use Observational Study With Beovu Kit for Intravitreal InjectionCompletedNCT05526729
- A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05521191Phase 1
- Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With PsoriasisCompletedNCT05513014
- An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With RemibrutinibActive, not recruitingNCT05513001Phase 3
- Open-label Safety and PK Study of BION-1301 in Japanese Healthy SubjectsCompletedNCT05508204Phase 1
- Characteristics of Patients With Sickle Cell DiseaseCompletedNCT05494541
- Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy ParticipantsWithdrawnNCT05490030Phase 1
- Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)CompletedNCT05488613
- Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) PatientsCompletedNCT05479981Phase 2
- Study Conducted Among Patients With CMLCompletedNCT05476562
- Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsActive, not recruitingNCT05469360Phase 1
- A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid TumorsTerminatedNCT05462873Phase 1
- Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.CompletedNCT05448872
- Study to Assess Iron Chelation Therapy in Patients With Chronic Iron OverloadCompletedNCT05440487
- In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy SubjectsCompletedNCT05429775Phase 1
- Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsTerminatedNCT05429502Phase 1
- Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.CompletedNCT05424523
- Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.CompletedNCT05421104
- Special Drug Use-results Surveillance of Scemblix TabletsCompletedNCT05421091
- A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant MelanomasActive, not recruitingNCT05415072Phase 1/2
- Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic SurgeryCompletedNCT05413980
- Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVDActive, not recruitingNCT05399992
- Study of PIT565 in Relapsed and/or Refractory B-cell MalignanciesActive, not recruitingNCT05397496Phase 1
- A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in ChinaCompletedNCT05388916
- Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous LeukemiaActive, not recruitingNCT05384587Phase 2
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 3
- Impact of Mayzent on aSPMS Patients in a Long-term NIS in ItalyCompletedNCT05376579
- Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities.CompletedNCT05375097
- An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data SourceCompletedNCT05368818
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy VolunteersTerminatedNCT05367661Phase 1
- A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS ParticipantsWithdrawnNCT05367401Phase 1/2
- Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)CompletedNCT05366257
- A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world SettingCompletedNCT05362903
- Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular EventsActive, not recruitingNCT05360446Phase 3
- Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationTerminatedNCT05358249Phase 1/2
- Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeCompletedNCT05350072Phase 3
- Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeActive, not recruitingNCT05349214Phase 3
- CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)CompletedNCT05349201
- Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT05344482
- Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical TrialsActive, not recruitingNCT05335876Phase 3
- A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple SclerosisCompletedNCT05334472
- Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.TerminatedNCT05330286Phase 1
- Drug-drug Interaction Study of Ganaplacide and Lumefantrine With EfavirenzCompletedNCT05330273Phase 1
- A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.CompletedNCT05329623Phase 1
- Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)CompletedNCT05328752Phase 1
- Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)CompletedNCT05320159
- Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic RhinitisCompletedNCT05311475Phase 3
- Regulatory PMS Study for Lucentis® in Patients With Retinopathy of PrematurityCompletedNCT05304949
- Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP MaterialsCompletedNCT05301907
- Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational StudyCompletedNCT05294289
- Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational StudyCompletedNCT05285904
- Study of MGY825 in Patients With Advanced Non-small Cell Lung CancerTerminatedNCT05275868Phase 1
- First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy VolunteersCompletedNCT05275855Phase 1
- A 24-week rPMS Study in Real-world Setting for EnerzairActive, not recruitingNCT05274425
- Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes MellitusWithdrawnNCT05272059Phase 1
- MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia VeraNo longer availableNCT05269771
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedNCT05268289Phase 2